Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer

Published:2019-10-01 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Kumar Sanjeev,Oien Derek B.,Khurana Ashwani,Cliby William,Hartmann Lynn,Chien Jeremy,Shridhar Viji

Funder

National Cancer Institute

American Cancer Society

Minnesota Ovarian Cancer Alliance

Mayo Clinic

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference48 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin.,2013

2. Cancer statistics, 2004;Jemal;CA Cancer J Clin.,2004

3. TP53 mutations as a biomarker for high-grade serous ovarian cancer: are we there yet?;Oien;Transl Cancer Res.,2016

4. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N Engl J Med.,1996

5. Pharmaceutical management of ovarian cancer: current status;Markman;Drugs.,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nonsense CC2D1A variant is associated with congenital anomalies, motor delay, hypotonia, and slight deformities;Heliyon;2024-03

2. TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis;Journal of Translational Medicine;2024-01-02

3. MetastaSite: Predicting metastasis to different sites using deep learning with gene expression data;Frontiers in Molecular Biosciences;2022-07-22

4. Quinacrine Has Preferential Anticancer Effects on Mesothelioma Cells With Inactivating NF2 Mutations;Frontiers in Pharmacology;2021-09-21

5. Overexpression of TC2N is associated with poor prognosis in gastric cancer;Journal of Cancer;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3